Muscle Jerking and Twitching in Dialysis Patients

Primary Mechanisms

• Electrolyte fluctuations, particularly magnesium, calcium, and potassium, are the dominant cause of neuromuscular irritability in dialysis patients, according to the American Journal of Kidney Diseases 1, 2
• The intermittent nature of hemodialysis creates wide swings in potassium, ionized calcium, magnesium, and other divalent ions between treatments, as reported by the American Journal of Kidney Diseases 1, 2
• Dialysate composition used during the treatment session contributes to electrolyte fluctuations, as noted by the American Journal of Kidney Diseases 1, 2
• Variable dietary adherence affecting calcium-phosphate product control also plays a role in electrolyte fluctuations, according to the American Journal of Kidney Diseases 1, 2

Critical Electrolyte Abnormalities to Evaluate

Hypomagnesemia

• Hypomagnesemia is a commonly overlooked cause of refractory muscle twitching and occurs in 60-65% of critically ill patients on continuous kidney replacement therapy, as reported by Praxis Medical Insights 3
• Target serum magnesium should be ≥0.70 mmol/L (approximately 1.7 mg/dL), according to Praxis Medical Insights 3, 4
• Hypomagnesemia causes refractory hypokalemia and hypocalcemia that cannot be corrected without magnesium replacement, as noted by Praxis Medical Insights 4

Hypocalcemia and Hypokalemia

• These often coexist with hypomagnesemia and will not respond to replacement unless magnesium is corrected first, according to Praxis Medical Insights 4

Aluminum Toxicity (Less Common but Serious)

• If muscle twitching is accompanied by speech disturbances, personality changes, or occurs shortly after dialysis, consider aluminum neurotoxicity, as reported by the American Journal of Kidney Diseases 5
• Dialysis encephalopathy presents with twitching, myoclonic jerks, and motor apraxia, according to the American Journal of Kidney Diseases 5
• Plasma aluminum levels are typically 150-350 µg/L in dialysis encephalopathy, as noted by the American Journal of Kidney Diseases 5
• Acute aluminum neurotoxicity causes agitation, confusion, myoclonic jerks, and major motor seizures with plasma aluminum 400-1,000 µg/L, according to the American Journal of Kidney Diseases 5

Arrhythmogenic Risk

• These same electrolyte fluctuations that cause muscle twitching also create a dysrhythmogenic state, as reported by the American Journal of Kidney Diseases and Circulation 1, 2, 6
• 76% of maintenance dialysis patients demonstrate varying degrees of ventricular dysrhythmias, according to the American Journal of Kidney Diseases 1, 2
• Arrhythmias often occur during hemodialysis sessions and for 4-5 hours afterward, as noted by Circulation 6
• Risk factors include compromised myocardium, increased QTc interval, electrolyte abnormalities, intradialytic hypotension, and LVH (present in 80% of dialysis patients), according to the American Journal of Kidney Diseases 1, 2

Immediate Management Algorithm

• Check electrolytes immediately: magnesium, calcium (ionized if possible), potassium, phosphate, as recommended by Circulation and Praxis Medical Insights 6, 3
• Assess dialysate composition: Determine current magnesium, calcium, and potassium concentrations in dialysate, according to Praxis Medical Insights 3, 7
• Correct magnesium FIRST if low: Use dialysis solutions containing magnesium rather than IV supplementation, as noted by Praxis Medical Insights 3
• Avoid exogenous IV supplementation during dialysis—it carries severe clinical risks, according to Praxis Medical Insights 3, 4

Critical Pitfalls to Avoid

• Do not treat hypokalemia or hypocalcemia without checking and correcting magnesium first—these will be refractory to replacement, as reported by Praxis Medical Insights 4
• Do not give IV magnesium supplementation to patients on dialysis—adjust dialysate composition instead, according to Praxis Medical Insights 3
• Do not assume post-dialysis electrolytes are stable—fluctuations continue for hours after treatment, as noted by Circulation and Praxis Medical Insights 6, 7
• Do not overlook aluminum toxicity if symptoms worsen after dialysis or include speech/cognitive changes, according to the American Journal of Kidney Diseases 5

Post-Dialysis Muscle Spasms: Etiology and Management

Primary Mechanism: Electrolyte Fluctuations and Management Strategies

• Excessive ultrafiltration leading to plasma volume contraction can trigger muscle cramps during and after dialysis, with plasma or muscle cell hypo-osmolality being a major co-factor, according to the American Journal of Kidney Diseases 8
• Patients with excessive weight gain between sessions are at higher risk for cramping when aggressive ultrafiltration is required, as reported by the American Journal of Kidney Diseases 8

Pharmacological Prevention and Treatment

• The American Association for the Study of Liver Diseases recommends starting baclofen at 10 mg/day with weekly increases of 10 mg/day up to 30 mg/day for recurrent and severe muscle spasms, supported by high-quality evidence 9, 10
• Albumin infusion (20-40 g/week) may relieve symptoms, particularly in patients with hypoalbuminemia, as suggested by the American Association for the Study of Liver Diseases 9, 10

Dialysis Prescription Modifications

• Adjusting the ultrafiltration rate and dialysate composition can prevent recurrence, including slowing the ultrafiltration rate, considering sodium ramping, reducing dialysate temperature, and extending treatment time, as recommended by the American Journal of Kidney Diseases 8

Monitoring Requirements

• Frequent measurements of serum creatinine, sodium, potassium, and other electrolytes are necessary during the first month of treatment, with monitoring for 4-5 hours post-dialysis, as suggested by the American Association for the Study of Liver Diseases 9, 10

Alternative Diagnoses

• If muscle spasms are accompanied by speech disturbances, personality changes, or worsen shortly after dialysis, consider aluminum neurotoxicity, with plasma aluminum levels typically 150-350 µg/L, as reported by the American Journal of Kidney Diseases 11

Post‑Dialysis Neurological Complications: Evidence‑Based Recommendations

Aluminum‑Related Neurotoxicity

• Dialysis‑associated encephalopathy due to aluminum – patients may develop myoclonic spasms and motor apraxia when plasma aluminum concentrations are in the range of 150–350 µg/L. 12
• Acute aluminum neurotoxicity – presents with agitation, confusion, myoclonic spasms, and major seizures when plasma aluminum levels rise to 400–1,000 µg/L. 12
• Plasma aluminum measurement – should be obtained in any patient with atypical neurological findings after a dialysis session to rule out aluminum toxicity. 12

Immediate Stabilization of Post‑Dialysis Seizures

• Airway protection and supplemental oxygen are recommended as the first steps in the emergency management of seizures occurring during or immediately after hemodialysis. 13

Clinical Vigilance After Dialysis

• Do not dismiss subtle neurological symptoms (e.g., mild confusion, speech changes) after a dialysis session; such findings may signal the need for additional dialysis treatment or a change in modality. 14